Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

NCT00128544 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

NCT00124241 ·Status: COMPLETED ·Phase: PHASE2

Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis

NCT00076336 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.

NCT00275652 ·Status: COMPLETED ·Phase: PHASE3

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

NCT00646503 ·Status: COMPLETED ·Phase: PHASE4

EFFicacy Optimization Research of Telbivudine Therapy

NCT00962533 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B

NCT00710216 ·Status: WITHDRAWN ·Phase: PHASE4

Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B

NCT00781105 ·Status: COMPLETED ·Phase: PHASE4

Efficacy Optimizing Research of Lamivudine Therapy

NCT01088009 ·Status: COMPLETED ·Phase: PHASE4

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00412529 ·Status: COMPLETED ·Phase: PHASE3

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

NCT00316719 ·Status: COMPLETED ·Phase: PHASE3

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00467545 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)

NCT01380951 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

NCT00804622 ·Status: COMPLETED ·Phase: PHASE2

Study of Telbivudine in Chronic Hepatitis B

NCT00970216 ·Status: COMPLETED

A Two-year Study of Telbivudine in HBeAg Negative Hepatitis

NCT01521975 ·Status: COMPLETED ·Phase: PHASE4

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

NCT00376259 ·Status: TERMINATED ·Phase: PHASE3

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

NCT01743079 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study

NCT01804387 ·Status: UNKNOWN ·Phase: PHASE4

EFFORT Extension Study

NCT01529255 ·Status: UNKNOWN ·Phase: PHASE4

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

NCT01013272 ·Status: COMPLETED ·Phase: NA

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

NCT01300234 ·Status: COMPLETED ·Phase: PHASE3

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

NCT00362635 ·Status: COMPLETED ·Phase: PHASE3